Effect of an educational intervention on human papillomavirus (HPV) knowledge and attitudes towards HPV vaccines among healthcare workers (HCWs) in Western China

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Chen WQ, Zheng RS, Zhang SW, Zeng HM, Zou TT, Xia CF, Yang ZX, He J. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res. 2017;29(1):1–10. doi:10.21147/j..1000-9604.2017.01.01.
   PubMed Web of Science ®Google Scholar
• Zhao FH, Hu SY, Zhang SW, Chen WQ, Qiao YL. Cervical cancer mortality in 2004-2005 and changes during last 30 years in China. Chin J Prev Med (Article in Chinese). 2010;44(5):408–12. doi:10.3760/cma.j..0253-9624.2010.05.009.
   Google Scholar
• Li J, Kang LN, Qiao YL. Review of the cervical cancer disease burden in Mainland China. Asian Pacific J Cancer Prev. 2011;12:1149–53. doi:10.1097/01.cad.0000390767.85658.83.
   PubMedGoogle Scholar
• Bosch FX, Muñoz N. The viral etiology of cervical cancer. Virus Res. 2002;89(2):183–90. doi:10.1016/S0168-1702(02)00187-9.
   PubMed Web of Science ®Google Scholar
• Erickson BK, Landers EE, Huh WK. Update on vaccination clinical trials for HPV-related disease. Clin Ther. 2014;36(1):8–16. doi:10.1016/j.clinthera.2013.11.003.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, et al. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia three cohorts from randomized trials. BMJ Open. 2017;7(8):1–8. doi:10.1136/bmjopen-2017-015867.
   Web of Science ®Google Scholar
• Kjaer SK, Nygård M, Dillner J, Marshall JB, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, et al. A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries. Clin Infect Dis. 2018;66(3):339–45. doi:10.1093/cid/cix797.
   PubMed Web of Science ®Google Scholar
• Huh WK, Joura EA, Giuliano AR, Iversen O, De ARP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16 – 26 years: a randomised, double-blind trial. Lancet. 2017;390(10108):2143–59. doi:10.1016/S0140-6736(17)31821-4.
   PubMed Web of Science ®Google Scholar
• Gallagher KE, Lamontagne DS, Watson-jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36(32):4761–67. doi:10.1016/j.vaccine.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Drolet M, Bénard É, Boily M, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JML, Cummings T, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2016;15(5):565–80. doi:10.1016/S1473-3099(14)71073-4.
   Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED, Ngan JY, Petersen LK, Lazcano-Ponce E, et al. A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women. N Engl J Med. 2015;372(8):711–23. doi:10.1056/NEJMoa1405044.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Palefsky JM, Goldstone S, Moreira EDJ, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. 2011;364(5):401‐411. doi:10.1056/NEJMoa0909537.
   PubMed Web of Science ®Google Scholar
• Wong LP, Han L, Li H, Zhao J, Zhao Q, Zimet GD. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects. Hum Vaccin Immunother. 2019;15(7–8):1533–40. doi:10.1080/21645515.2019.1611157.
   PubMed Web of Science ®Google Scholar
• National Medical Products Administration. The license of human papillomavirus bivalent(types 16, 18) vaccine was approved by CFDA. Beijing: National Medical Products Administration; 2016. [accessed 2020 May 13July18]. http://www.nmpa.gov.cn/WS04/CL2168/329384.html.
   Google Scholar
• Deng HN, Wang B The license of human papillomavirus quadrivalent (Types6,11, 16, 18) Vaccine was approved by CFDA. The Xinhua News Agency. 2017 Jun 20. accessed 2020 May 13. http://www.xinhuanet.com/2017-06/20/c_1121179041.htm.
   Google Scholar
• National Medical Products Administration. Nine-valent HPV vaccine has been conditionally approved for marketing. Beijing: National Medical Products Administration; 2018. [accessed 2020 May 13Apr29]. http://www.nmpa.gov.cn/WS04/CL2094/227881.html.
   Google Scholar
• National Medical Products Administration. The vaccine to prevent cervical cancer is suitable for women of which age? Beijing: National Medical Products Administration; 2019. [accessed 2020 May 13July18]. http://www.nmpa.gov.cn/WS04/CL2056/338922.html.
   Google Scholar
• Liu Y, Di N, Tao X. Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China[J]. Hum Vaccin Immunother. 2020;16(1):116–23. doi:10.1080/21645515.2019.1638727.
   PubMed Web of Science ®Google Scholar
• Li J, Li LK, Ma JF, Wei LH, Niyazi M, Li CQ, Xu AD, Wang JB, Liang H, Belinson J, et al. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine. 2009;27(8):1210–15. doi:10.1016/j.vaccine.2008.12.020.
   PubMed Web of Science ®Google Scholar
• Pampena E, Vanucci R, Johnson LB, Bind MA, Tamayo I, Welch K, Lind E, Wagner R, Villa A. Educational interventions on human papillomavirus for oral health providers. J Cancer Edu. 2019. doi:10.1007/s13187-019-01512-7.
   Web of Science ®Google Scholar
• Berenson AB, Rahman M, Hirth JM, Rupp RE, Sarpong KO. A brief educational intervention increases providers’ human papillomavirus vaccine knowledge A brief educational intervention increases providers’ human papillomavirus vaccine knowledge. Hum Vaccin Immunother. 2015;11(6):1331–36. doi:10.1080/21645515.2015.1022691.
   PubMed Web of Science ®Google Scholar
• Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US national immunization survey. Am J Public Health. 2013;103(1):164–69. doi:10.2105/AJPH.2011.300600.
   PubMed Web of Science ®Google Scholar
• Hswen Y, Gilkey MB, Rimer BK, Brewer NT. Improving physician recommendations for human papillomavirus vaccination: the role of professional organizations. Sex Transm Dis. 2017;44(1):43–48. doi:10.1097/OLQ.0000000000000543.
   Web of Science ®Google Scholar
• Rahman M, Laz TH, Mcgrath CJ, Berenson AB. Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-Year-Old US adolescent children. Clin Pediatr (Phila). 2015;54(4):371–75. doi:10.1177/0009922814551135.
   PubMed Web of Science ®Google Scholar
• Li J, Kang LN, Li BY, Pang Y, Huang R, Qiao YL. Effect of a group educational intervention on rural Chinese women’ s knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines. BMC Cancer. 2015;15(1):1–11. doi:10.1186/s12885-015-1682-2.
   PubMedGoogle Scholar
• Liu CR, Liang H, Zhang X, Pu C, Li Q, Li QL, Ren FY, Li J. Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China. BMC Public Health. 2019;19(1):1–9. doi:10.1186/s12889-019-6823-0.
   PubMedGoogle Scholar
• Pu C, Liu CR, Zhang X, Li J. Knowledge and attitudes toward HPV and its vaccines among parents of middle school students in Chengdu. Mod Preventive Med. 2018;45(2):299–303. Article in Chinese.
   Google Scholar
• Chang IJ, Huang R, He W, Zhang SK, Wang SM, Zhao FH, Smith JS, Qiao YL. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China : a cross-sectional study. BMC Public Health. 2013;13(1):916. doi:10.1186/1471-2458-13-916.
   PubMed Web of Science ®Google Scholar
• Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, Sellors JW, Franceschi S, Qiao YL, Castle PE, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer : a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol. 2010;11(12):1160–71. doi:10.1016/S1470-2045(10)70256-4.
   PubMed Web of Science ®Google Scholar
• Kim HW. Knowledge about human papillomavirus (HPV), and health beliefs and intention to recommend HPV vaccination for girls and boys among Korean health teachers. Vaccine. 2012;30(36):5327–34. doi:10.1016/j.vaccine.2012.06.040.
   PubMed Web of Science ®Google Scholar
• Patel H, Austin-Smith K, Sherman SM, Tincello D, Moss EL. Knowledge, attitudes and awareness of the human papillomavirus amongst primary care practice nurses: an evaluation of current training in England. J Public Health (Bangkok). 2016:1–8. doi:10.1093/pubmed/fdw063.
   Google Scholar
• Zhang YR, Wang Y, Liu L, Fan YZ, Liu ZH, Wang YY, Nie SF. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. BMC Public Health. 2016;16(1):216. doi:10.1186/s12889-016-2873-8.
   PubMedGoogle Scholar
• Levin C, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine. 2013;33(24):295–306. doi:10.1016/j.vaccine.2015.02.052.
   Web of Science ®Google Scholar
• Xu HH, Wang K, Feng XJ, Dong SS, Lin A, Zheng LZ, Yan WH. Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta- analysis. Oncotarget. 2018;9(20):15386–97. doi:10.18632/oncotarget.24169.
   PubMedGoogle Scholar
• Choules AP. The use of e-learning in medical education: a review of the current situation. Postgrad Med J. 2007;83(978):212–16. doi:10.1136/pgmj.2006.054189.
   PubMed Web of Science ®Google Scholar
• Choma K, Mckeever WAE. Cervical cancer screening in adolescents: an evidence-based internet education program for practice improvement among advanced practice nurses. Worldviews on Evidence-Based Nurs. 2015;12(1):51–60. doi:10.1111/wvn.12071.
   PubMed Web of Science ®Google Scholar
• Bennett AT, Patel DA, Carlos RC, Zochowski MK, Pennewell SM, Chi AM, Dalton VK. Human papillomavirus vaccine uptake for female university students: a randomized controlled trial. J Women’s Health. 2015;24(11):950–57. doi:10.1089/jwh.2015.5251.
   PubMed Web of Science ®Google Scholar